Seres Therapeutics, Inc. (MCRB)
USD 0.86
(-2.31%)
USD 0.86
(-2.31%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 213.93 Million USD | 31.58% |
| 2022 | 162.59 Million USD | 230.39% |
| 2021 | 49.21 Million USD | 20.71% |
| 2020 | 40.76 Million USD | -8.96% |
| 2019 | 44.78 Million USD | 517.66% |
| 2018 | 7.25 Million USD | -19.35% |
| 2017 | 8.98 Million USD | -16.23% |
| 2016 | 10.73 Million USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 2.5 Million USD | 198.81% |
| 2013 | 838 Thousand USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 212.62 Million USD | -0.73% |
| 2024 Q1 | 214.18 Million USD | 0.12% |
| 2023 Q4 | 213.93 Million USD | 0.78% |
| 2023 FY | 213.93 Million USD | 31.58% |
| 2023 Q1 | 162.71 Million USD | 0.07% |
| 2023 Q2 | 212.91 Million USD | 30.86% |
| 2023 Q3 | 212.27 Million USD | -0.3% |
| 2022 Q2 | 77.2 Million USD | -0.55% |
| 2022 FY | 162.59 Million USD | 230.39% |
| 2022 Q4 | 162.59 Million USD | 113.82% |
| 2022 Q3 | 76.04 Million USD | -1.51% |
| 2022 Q1 | 77.63 Million USD | 57.75% |
| 2021 Q1 | 39.65 Million USD | -2.73% |
| 2021 Q2 | 44.83 Million USD | 13.07% |
| 2021 FY | 49.21 Million USD | 20.71% |
| 2021 Q3 | 43.79 Million USD | -2.33% |
| 2021 Q4 | 49.21 Million USD | 12.37% |
| 2020 Q4 | 40.76 Million USD | -2.52% |
| 2020 Q1 | 43.82 Million USD | -2.14% |
| 2020 FY | 40.76 Million USD | -8.96% |
| 2020 Q2 | 42.83 Million USD | -2.26% |
| 2020 Q3 | 41.82 Million USD | -2.36% |
| 2019 Q3 | 21.17 Million USD | -5.53% |
| 2019 Q2 | 22.41 Million USD | -4.49% |
| 2019 Q1 | 23.47 Million USD | 223.77% |
| 2019 FY | 44.78 Million USD | 517.66% |
| 2019 Q4 | 44.78 Million USD | 111.44% |
| 2018 Q1 | 8.55 Million USD | -4.84% |
| 2018 Q2 | 8.11 Million USD | -5.09% |
| 2018 Q3 | 7.68 Million USD | -5.35% |
| 2018 FY | 7.25 Million USD | -19.35% |
| 2018 Q4 | 7.25 Million USD | -5.66% |
| 2017 Q4 | 8.98 Million USD | -4.62% |
| 2017 FY | 8.98 Million USD | -16.23% |
| 2017 Q3 | 9.42 Million USD | -4.41% |
| 2017 Q2 | 9.85 Million USD | -4.24% |
| 2017 Q1 | 10.29 Million USD | -4.05% |
| 2016 FY | 10.73 Million USD | 0.0% |
| 2016 Q4 | 10.73 Million USD | -0.09% |
| 2016 Q3 | 10.74 Million USD | 17.78% |
| 2016 Q2 | 9.11 Million USD | 101.44% |
| 2016 Q1 | 4.52 Million USD | 0.0% |
| 2015 Q1 | 2.21 Million USD | -11.5% |
| 2015 FY | - USD | -100.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q2 | 1.92 Million USD | -13.04% |
| 2014 Q4 | 2.5 Million USD | -10.19% |
| 2014 FY | 2.5 Million USD | 198.81% |
| 2014 Q3 | 2.78 Million USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2013 FY | 838 Thousand USD | 0.0% |
| 2013 Q4 | 838 Thousand USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 6.754% |
| IO Biotech, Inc. | 2.49 Million USD | -8478.027% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -99870.093% |
| Organovo Holdings, Inc. | 1.39 Million USD | -15246.915% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -437665.5% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -130375.035% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2080.128% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -2945.786% |
| Savara Inc. | 26.73 Million USD | -700.12% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -31594.222% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -754.309% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -924.39% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2471434.196% |
| Soligenix, Inc. | 3.49 Million USD | -6021.971% |
| Aptose Biosciences Inc. | 1 Million USD | -21085.852% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -973.922% |
| Century Therapeutics, Inc. | 48.17 Million USD | -344.118% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -411.283% |
| Precision BioSciences, Inc. | 31.26 Million USD | -584.201% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -14.79% |
| Kura Oncology, Inc. | 17.2 Million USD | -1143.814% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -156138.635% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -131.45% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -7349.025% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1430.957% |
| Autolus Therapeutics plc | 52.96 Million USD | -303.904% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3821.833% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3811.794% |
| GRI Bio, Inc. | 14 Thousand USD | -1528014.286% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1621.958% |
| IGM Biosciences, Inc. | 40.5 Million USD | -428.159% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -19.099% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3521.701% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -25773.804% |
| Opthea Limited | 200.62 Million USD | -6.633% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -267.077% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -269.671% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1781.252% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3370.17% |
| Surrozen, Inc. | 3.37 Million USD | -6231.341% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -6723.899% |
| Ovid Therapeutics Inc. | 46 Million USD | -365.061% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -59.055% |
| Acelyrin, Inc. | 1.19 Million USD | -17817.588% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -152.915% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -102251.928% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -608.022% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -244.641% |
| ADMA Biologics, Inc. | 141.41 Million USD | -51.279% |
| PureTech Health plc | 25.51 Million USD | -738.57% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -67175.472% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -12145.907% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1548.705% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -152.658% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -86513.765% |
| ChromaDex Corporation | 3.27 Million USD | -6428.41% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -34294.689% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -12.631% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -105.348% |
| Better Therapeutics, Inc. | 14.88 Million USD | -1337.742% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -598.818% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -92.86% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -461.453% |
| Seer, Inc. | 28.25 Million USD | -657.054% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -3389.984% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -3288.817% |
| Gritstone bio, Inc. | 104.77 Million USD | -104.186% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7578.966% |
| Avid Bioservices, Inc. | 207.83 Million USD | -2.936% |
| Insmed Incorporated | 1.2 Billion USD | 82.231% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -4018.906% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -5381.322% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -106.63% |
| MediWound Ltd. | 6.71 Million USD | -3087.841% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -111.016% |
| Fortress Biotech, Inc. | 88.59 Million USD | -141.485% |
| OmniAb, Inc. | 25.56 Million USD | -736.963% |
| Zai Lab Limited | 15.15 Million USD | -1312.026% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 55.284% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -574.196% |
| Veracyte, Inc. | 12.63 Million USD | -1593.872% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3861.778% |
| FibroGen, Inc. | 170.45 Million USD | -25.509% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -10417.999% |
| ContextLogic Inc. | 6 Million USD | -3465.6% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -135302.532% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -3161.717% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.309% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -213.551% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -578105.405% |
| ImmuCell Corporation | 11.96 Million USD | -1687.372% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 87.251% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2823.821% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7578.966% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -374.643% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -395.578% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -372.933% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -343.584% |
| Vaxxinity, Inc. | 15.16 Million USD | -1310.443% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 74.793% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -20723.089% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1507128.406% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -907.279% |
| Senti Biosciences, Inc. | 37.66 Million USD | -467.982% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -131701.352% |
| Apollomics, Inc. | 4.66 Million USD | -4489.916% |
| 89bio, Inc. | 27.1 Million USD | -689.199% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -85.755% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -47381.085% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -2997.828% |
| Ardelyx, Inc. | 55.98 Million USD | -282.151% |
| Pluri Inc. | 29.61 Million USD | -622.464% |
| Prothena Corporation plc | 11.83 Million USD | -1707.655% |
| Pulmatrix, Inc. | 8.75 Million USD | -2343.307% |
| Celularity Inc. | 65.41 Million USD | -227.034% |
| MeiraGTx Holdings plc | 89.26 Million USD | -139.667% |
| Omeros Corporation | 338.28 Million USD | 36.758% |
| Ainos, Inc. | 5.96 Million USD | -3487.39% |
| Humacyte, Inc. | 58.1 Million USD | -268.182% |
| Mesoblast Limited | 118.92 Million USD | -79.895% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -11445.386% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -4286.631% |
| Blueprint Medicines Corporation | 774.12 Million USD | 72.364% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -4163.372% |
| Summit Therapeutics Inc. | 106.09 Million USD | -101.638% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -246.074% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -85.473% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -578.128% |
| Cytokinetics, Incorporated | 755.77 Million USD | 71.693% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -1498.446% |
| Nutriband Inc. | 241.28 Thousand USD | -88565.271% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3813.225% |
| Roivant Sciences Ltd. | 499.74 Million USD | 57.191% |
| Evogene Ltd. | 1.13 Million USD | -18699.297% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -17349.918% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -387711.112% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 87.704% |
| BioLineRx Ltd. | 11.59 Million USD | -1745.708% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1198.471% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -9991.321% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -119.181% |
| MediciNova, Inc. | 215.92 Thousand USD | -98978.388% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -8474.589% |
| MiMedx Group, Inc. | 48.09 Million USD | -344.783% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 48.452% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -5859.22% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -12984.771% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -261819.687% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2235.291% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1358.224% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -680.361% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1645.277% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1610.667% |
| Allakos Inc. | 41.46 Million USD | -415.944% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1877.045% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -141579.47% |
| BioAtla, Inc. | 2.46 Million USD | -8596.585% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -124.909% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -3757.483% |
| Precigen, Inc. | 7.09 Million USD | -2914.457% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 124.45 Million USD | -71.905% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1029.964% |
| Incyte Corporation | 38.28 Million USD | -458.769% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -395.601% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1820.776% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 10.349% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -721.472% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -61199.713% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -65425.448% |
| UroGen Pharma Ltd. | 100.21 Million USD | -113.479% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -17.065% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -61670.158% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -70042.951% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -3030.007% |
| Chimerix, Inc. | 2.14 Million USD | -9878.358% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -501.7% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -123796.614% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -706.91% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -455082.979% |
| OncoCyte Corporation | 2.86 Million USD | -7356.814% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -16366.546% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1001942.155% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -141999.18% |
| Purple Biotech Ltd. | 351 Thousand USD | -60850.427% |
| NextCure, Inc. | 6.6 Million USD | -3139.001% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -118.538% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -3989.773% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 6.656% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -22000.826% |
| NLS Pharmaceutics AG | 1.63 Million USD | -12994.814% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | 23.767% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -7556.979% |
| Daré Bioscience, Inc. | 5.31 Million USD | -3922.756% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -37764.779% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -375.879% |
| BeiGene, Ltd. | 930.18 Million USD | 77.001% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -1276.458% |
| Alector, Inc. | 38.91 Million USD | -449.71% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -18649.869% |
| Erasca, Inc. | 55.85 Million USD | -282.993% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -993.91% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -737.126% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -54475.232% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 81.132% |
| Histogen Inc. | 4.62 Million USD | -4528.646% |
| Fortress Biotech, Inc. | 88.59 Million USD | -141.485% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2071.498% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -238.683% |
| Galecto, Inc. | 249 Thousand USD | -85818.072% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 66.825% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -53.878% |
| Molecular Templates, Inc. | 12.23 Million USD | -1649.272% |
| PDS Biotechnology Corporation | 23.85 Million USD | -796.945% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -4949.233% |
| Amarin Corporation plc | 8.73 Million USD | -2348.621% |
| TG Therapeutics, Inc. | 110.79 Million USD | -93.092% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3863.98% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -8316.05% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1034.758% |
| Onconetix, Inc. | 9.88 Million USD | -2064.08% |
| MacroGenics, Inc. | 33.97 Million USD | -529.761% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -14976.533% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -859.059% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -1.806% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1852.862% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -954.235% |
| SciSparc Ltd. | 76 Thousand USD | -281394.737% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -160.844% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -64926.14% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -745.664% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -3.895% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -300.135% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 92.025% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2693.848% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -339480.952% |
| 2seventy bio, Inc. | 256.67 Million USD | 16.65% |
| Clene Inc. | 32.16 Million USD | -565.203% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -9646.515% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -104816.361% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2353.113% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -1240.703% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1144.031% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -695.863% |
| Entera Bio Ltd. | 390 Thousand USD | -54755.385% |
| Trevena, Inc. | 35.23 Million USD | -507.203% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -747.775% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -678.374% |
| INmune Bio, Inc. | 10.43 Million USD | -1949.784% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -44354.696% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -3193.35% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -521695.122% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -692.649% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -42610.066% |
| Jaguar Health, Inc. | 35.86 Million USD | -496.587% |
| Clearside Biomedical, Inc. | 43 Million USD | -397.514% |
| NexImmune, Inc. | 68.8 Thousand USD | -310812.817% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -45907.742% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -17375.205% |
| Kronos Bio, Inc. | 28.27 Million USD | -656.706% |
| Innoviva, Inc. | 449.07 Million USD | 52.361% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 55.508% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 92.085% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -958.094% |
| Verastem, Inc. | 41.55 Million USD | -414.801% |
| ProKidney Corp. | 4.41 Million USD | -4747.859% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -13657.942% |
| Imunon, Inc. | 1.62 Million USD | -13067.61% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -16879.048% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1215.627% |
| ImmunityBio, Inc. | 883.67 Million USD | 75.79% |
| Korro Bio, Inc. | 33.2 Million USD | -544.25% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 47.148% |
| Kineta, Inc. | 1.31 Million USD | -16144.191% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -5914.507% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3712.012% |
| GT Biopharma, Inc. | 58 Thousand USD | -368755.172% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1381.141% |
| Celularity Inc. | 65.41 Million USD | -227.034% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -313.579% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -768.917% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -201.42% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -93.856% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -55757.963% |
| Kodiak Sciences Inc. | 181.63 Million USD | -17.785% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -105.518% |
| Annexon, Inc. | 31.35 Million USD | -582.303% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -185.111% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -9034.757% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -2992.902% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1444.664% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 85.282% |
| Vor Biopharma Inc. | 35.66 Million USD | -499.933% |
| Eyenovia, Inc. | 16.1 Million USD | -1228.155% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -53384.0% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -91.888% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -364.684% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -566.094% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -21619.391% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -273.981% |
| Immunocore Holdings plc | 84.03 Million USD | -154.589% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -449.681% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -197.932% |
| Alkermes plc | 290.73 Million USD | 26.414% |
| Arcellx, Inc. | 97.62 Million USD | -119.141% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -8628.533% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -367.385% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -329032.308% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -6796.712% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -16865.206% |
| Moolec Science SA | 2.64 Million USD | -7987.434% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1977.855% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -149.055% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3494.355% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -370.086% |
| Royalty Pharma plc | 6.13 Billion USD | 96.513% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -8806.578% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -12741.297% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -185521.323% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -532.385% |
| Humacyte, Inc. | 58.1 Million USD | -268.182% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3823.271% |
| NLS Pharmaceutics AG | 1.63 Million USD | -12994.814% |
| Genelux Corporation | 2.51 Million USD | -8392.894% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -266228.055% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1317.264% |
| Notable Labs, Ltd. | 2.04 Million USD | -10340.996% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -71042.68% |
| Mustang Bio, Inc. | 2.49 Million USD | -8464.291% |
| Immunovant, Inc. | 138 Thousand USD | -154926.087% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -13011.033% |
| Vericel Corporation | 88.14 Million USD | -142.715% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 85.73% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -632.056% |
| Orgenesis Inc. | 22.62 Million USD | -845.741% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -4541.701% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -105287.192% |
| GH Research PLC | 343 Thousand USD | -62272.012% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -935.458% |
| PepGen Inc. | 20.1 Million USD | -964.146% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -37171.08% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -211717.822% |
| Belite Bio, Inc | 886 Thousand USD | -24046.275% |
| Pharming Group N.V. | 171.54 Million USD | -24.711% |
| XOMA Corporation | 124.45 Million USD | -71.905% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -21887.256% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 10.718% |
| Xencor, Inc. | 83.43 Million USD | -156.413% |
| Replimune Group, Inc. | 75.86 Million USD | -181.981% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -902.935% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2174.947% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -6556.378% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1171.159% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -8751.303% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -16865.206% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -189223.894% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -20630.233% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -6672.27% |
| scPharmaceuticals Inc. | 40.26 Million USD | -431.267% |
| HilleVax, Inc. | 51.19 Million USD | -317.901% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -298.332% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2255.864% |
| Immunic, Inc. | 1.33 Million USD | -15937.181% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -6262.604% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -52985.856% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2255.864% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -9913.625% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1178.68% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -9850.512% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 51.931% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -73761.961% |
| bluebird bio, Inc. | 330.32 Million USD | 35.235% |
| DBV Technologies S.A. | 14.38 Million USD | -1387.63% |
| Compugen Ltd. | 1.35 Million USD | -15735.381% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -1895.335% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -8450.6% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3346.134% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -12581.446% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -400.248% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -4506.718% |
| Benitec Biopharma Inc. | 284 Thousand USD | -75229.577% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -153.014% |
| Adicet Bio, Inc. | 20.92 Million USD | -922.443% |
| Prime Medicine, Inc. | 13.63 Million USD | -1469.251% |
| Aditxt, Inc. | 18.21 Million USD | -1074.312% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -82.55% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1298.0% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -26364.061% |
| PolyPid Ltd. | 11.77 Million USD | -1716.249% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -133.917% |
| Invivyd, Inc. | 2.16 Million USD | -9781.57% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -6071193.771% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -253.152% |
| CorMedix Inc. | 667.63 Thousand USD | -31944.0% |
| Instil Bio, Inc. | 86.05 Million USD | -148.607% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -322.198% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -10.738% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -610.137% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -3759.571% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1511.449% |
| AbCellera Biologics Inc. | 77.38 Million USD | -176.475% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -156.552% |
| Surrozen, Inc. | 3.37 Million USD | -6231.341% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -771.714% |
| Verona Pharma plc | 51.32 Million USD | -316.794% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -35378.607% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -71.781% |
| Evaxion Biotech A/S | 10.86 Million USD | -1868.191% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -185.602% |
| Shattuck Labs, Inc. | 4.2 Million USD | -4991.29% |
| AlloVir, Inc. | 27.42 Million USD | -679.963% |
| BioVie Inc. | 6.11 Million USD | -3400.579% |
| Codexis, Inc. | 22.36 Million USD | -856.609% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -23513.245% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -130375.035% |
| Agenus Inc. | 350.24 Million USD | 38.918% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -95279.403% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -91141.987% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -916.42% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1000.211% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -471.314% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -9855.142% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -650.995% |
| IN8bio, Inc. | 4.89 Million USD | -4272.287% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -15889.238% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -101.705% |
| Liquidia Corporation | 3.5 Million USD | -6007.222% |
| Quantum-Si incorporated | 15.3 Million USD | -1298.0% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -261819.687% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1862.176% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -12842.287% |
| United Therapeutics Corporation | 700 Million USD | 69.438% |
| Solid Biosciences Inc. | 26.26 Million USD | -714.529% |
| Immuneering Corporation | 4.46 Million USD | -4693.591% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1511.449% |
| uniQure N.V. | 138.4 Million USD | -54.568% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1767.295% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -150.443% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -44939.158% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1510.236% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -101537.615% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1355.842% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -77978.832% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -609.878% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -21619.391% |
| Immunome, Inc. | 1.65 Million USD | -12865.818% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -12244.836% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2087.932% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -608.181% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -58998.343% |
| Altimmune, Inc. | 671 Thousand USD | -31783.159% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -313.203% |
| Rallybio Corporation | 392 Thousand USD | -54475.51% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -5016.862% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -36470.256% |
| Moolec Science SA | 2.64 Million USD | -7987.434% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -51450.843% |
| NeurAxis, Inc. | 224.26 Thousand USD | -95296.415% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 64.984% |
| Lumos Pharma, Inc. | 6.58 Million USD | -3148.838% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2087.932% |
| 180 Life Sciences Corp. | 1.32 Million USD | -16106.426% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -973.922% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1152.544% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -13657.942% |
| Nutriband Inc. | 241.28 Thousand USD | -88565.271% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -25800.242% |
| argenx SE | 20 Million USD | -969.68% |
| Neurogene Inc. | 16.25 Million USD | -1216.124% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 30.572% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -649.574% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -1100.943% |
| Design Therapeutics, Inc. | 3.05 Million USD | -6914.295% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -81554.962% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1403.627% |
| Achilles Therapeutics plc | 4.61 Million USD | -4535.666% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -150559.155% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1994.742% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 42.755% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -610.774% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -5685.391% |
| Palisade Bio, Inc. | 369 Thousand USD | -57877.236% |
| Beam Therapeutics Inc. | 173.17 Million USD | -23.539% |
| AEON Biopharma, Inc. | 278 Thousand USD | -76855.396% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -63761.493% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -200044.072% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -182.007% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -250.101% |
| Athira Pharma, Inc. | 1.58 Million USD | -13397.539% |
| Vaccinex, Inc. | 247 Thousand USD | -86513.765% |
| HCW Biologics Inc. | 6.45 Million USD | -3215.924% |
| XOMA Corporation | 124.45 Million USD | -71.905% |
| Nektar Therapeutics | 230.4 Million USD | 7.146% |
| Arvinas, Inc. | 3.4 Million USD | -6192.235% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -13011.033% |
| Merus N.V. | 12.16 Million USD | -1659.053% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -66.58% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1448.69% |
| Rezolute, Inc. | 2.22 Million USD | -9502.154% |
| Clene Inc. | 32.16 Million USD | -565.203% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -122112.13% |
| BeyondSpring Inc. | 3.99 Million USD | -5255.094% |
| Synlogic, Inc. | 17.27 Million USD | -1138.414% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -16356.615% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -611145.714% |
| Peak Bio, Inc. | 10.72 Million USD | -1895.335% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -312.025% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2543.143% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -20.857% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -2931.543% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -156521.814% |
| MannKind Corporation | 382.37 Million USD | 44.051% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1892.326% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -52207.09% |
| Gossamer Bio, Inc. | 212.46 Million USD | -0.693% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -122851.724% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2235.291% |
| Legend Biotech Corporation | 328.67 Million USD | 34.909% |
| Mural Oncology plc | 15 Million USD | -1325.385% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -351.094% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -10082.58% |
| Champions Oncology, Inc. | 7.43 Million USD | -2779.354% |
| REGENXBIO Inc. | 89.29 Million USD | -139.597% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -24930.625% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -38587.697% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3851.533% |
| Vaxart, Inc. | 26.51 Million USD | -706.879% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1266.361% |
| Cellectis S.A. | 92.85 Million USD | -130.403% |
| Longeveron Inc. | 2.04 Million USD | -10381.921% |
| Repare Therapeutics Inc. | 3.41 Million USD | -6173.783% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 84.684% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -359.169% |
| Revolution Medicines, Inc. | 87.94 Million USD | -143.264% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -123562.428% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -5311.991% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -67387.697% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -122149.143% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 73.536% |
| Denali Therapeutics Inc. | 52.24 Million USD | -309.517% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1385.103% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -15470.306% |
| Cingulate Inc. | 3.13 Million USD | -6723.899% |
| Passage Bio, Inc. | 26.29 Million USD | -713.63% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -3109.842% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -52335.294% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -23830.201% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -143.264% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -940.494% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -16879.048% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -8628.088% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -6750.336% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -26279.285% |
| OmniAb, Inc. | 25.56 Million USD | -736.963% |
| Anew Medical, Inc. | 1.6 Million USD | -13229.346% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -623.175% |
| Lipocine Inc. | 17.16 Thousand USD | -1246177.525% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1738.254% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -517.812% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3521.701% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -274.191% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -105287.192% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -4042.033% |
| Ocugen, Inc. | 6.94 Million USD | -2982.207% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1414.162% |
| Q32 Bio Inc. | 1.31 Million USD | -16131.866% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -31735.714% |
| Alumis Inc. Common Stock | 32.58 Million USD | -556.648% |
| Equillium, Inc. | 824 Thousand USD | -25863.107% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2256.383% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -71020.922% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -40.471% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -318.35% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -27502.936% |
| Dominari Holdings Inc. | 3.02 Million USD | -6965.258% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -226318.449% |
| vTv Therapeutics Inc. | 529 Thousand USD | -40341.588% |
| Bio-Techne Corporation | 419.53 Million USD | 49.007% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -197.15% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -10.524% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1166.793% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -839.882% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3431.463% |
| Nkarta, Inc. | 88.33 Million USD | -142.176% |
| BioCardia, Inc. | 1.31 Million USD | -16168.897% |
| Iterum Therapeutics plc | 19.5 Million USD | -996.602% |